SCOPUS 정보 검색 플랫폼

Chromatographia

Volumn 74, Issue 1-2, 2011, Pages 41-49

LC-MS-MS quantitative determination of gefitinib in human serum and cerebrospinal fluid

(7) Zheng, Xin a Hu, Pei a Liu, Jian a Zhao, Qian a Wang, Mengzhao a Jiang, Ji a Zhong, Wei a

a PEKING UNION MEDICAL COLLEGE HOSPITAL (China)

Author keywords

Brain metastases; CSF; Gefitinib; Human serum; LC MS MS

Indexed keywords

ANTINEOPLASTIC AGENT; GEFITINIB; ICOTINIB; UNCLASSIFIED DRUG;

ARTICLE; BRAIN METASTASIS; CANCER PATIENT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; ELECTROSPRAY; HUMAN; LIQUID CHROMATOGRAPHY; LUNG CANCER; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 79959376800 PISSN: 00095893 EISSN: 16121112 Source Type: Journal
DOI: 10.1007/s10337-011-2042-2 Document Type: Article

Times cited : (9)

References (16)

1
- 77957812460
- 10.1016/j.suronc.2010.07.002
- T Katayama K Matsuo T Kosaka T Sueda Y Yatabe T Mitsudomi 2010 Surg Oncol 19 e144 e149 10.1016/j.suronc.2010.07.002
- (2010) Surg Oncol , vol.19
- Katayama, T.¹ Matsuo, K.² Kosaka, T.³ Sueda, T.⁴ Yatabe, Y.⁵ Mitsudomi, T.⁶

2
- 22844447077
- Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry
- DOI 10.1016/j.jchromb.2005.01.027
- M Zhao C Hartke A Jimeno J Li P He Y Zabelina M Hidalgo SD Baker 2005 J Chromatogr B Analyt Technol Biomed Life Sci 819 73 80 10.1016/j.jchromb.2005.01. 027 1:CAS:528:DC%2BD2MXis1Gltbs%3D (Pubitemid 41583164)
- (2005) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.819 , Issue.1 , pp. 73-80
- Zhao, M.¹ Hartke, C.² Jimeno, A.³ Li, J.⁴ He, P.⁵ Zabelina, Y.⁶ Hidalgo, M.⁷ Baker, S.D.⁸

3
- 0034068319
- 1:CAS:528:DC%2BD3cXktVWitrs%3D
- F Ciardiello R Caputo R Bianco 2000 Clin Cancer Res 6 2053 2063 1:CAS:528:DC%2BD3cXktVWitrs%3D
- (2000) Clin Cancer Res , vol.6 , pp. 2053-2063
- Ciardiello, F.¹ Caputo, R.² Bianco, R.³

4
- 0012401048
- Abstract # 4248
- Iwata K, Miller PE, Barbacci EG, Arnold L, Doty J, DiOrio CI, Pustilnik LR, Reynolds M, Thelemann A, Sloan D, Moyer JD (1997) Proc Am Assoc Cancer Res 38:633 (Abstract # 4248)
- (1997) Proc Am Assoc Cancer Res , vol.38 , pp. 633
- Iwata, K.¹ Miller, P.E.² Barbacci, E.G.³ Arnold, L.⁴ Doty, J.⁵ Diorio, C.I.⁶ Pustilnik, L.R.⁷ Reynolds, M.⁸ Thelemann, A.⁹ Sloan, D.¹⁰ Moyer, J.D.¹¹

5
- 0034489914
- 1:CAS:528:DC%2BD3MXotlektQ%3D%3D
- FM Sirotnak MF Zakowski VA Miller 2000 Clin Cancer Res 6 4885 4892 1:CAS:528:DC%2BD3MXotlektQ%3D%3D
- (2000) Clin Cancer Res , vol.6 , pp. 4885-4892
- Sirotnak, F.M.¹ Zakowski, M.F.² Miller, V.A.³

6
- 4143110253
- Gefitinib in patients with brain metastasesfrom non-small-cell lung cancer: A prospective trial
- DOI 10.1093/annonc/mdh276
- GL Ceresoli F Cappuzo V Gregorc S Bartolini L Crino E Villa 2004 Ann Oncol 15 1042 1047 10.1093/annonc/mdh276 1:STN:280:DC%2BD2czgt1Squg%3D%3D (Pubitemid 39089780)
- (2004) Annals of Oncology , vol.15 , Issue.7 , pp. 1042-1047
- Ceresoli, G.L.¹ Cappuzzo, F.² Gregorc, V.³ Bartolini, S.⁴ Crino, L.⁵ Villa, E.⁶

7
- 1642306919
- Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals
- DOI 10.1038/sj.npp.1300372
- JS Wang R Taylor Y Ruan JL Donovan JS Markowitz C Lindsay De Vane 2004 Neuropsychopharmacology 29 551 557 10.1038/sj.npp.1300372 1:CAS:528: DC%2BD2cXhtlWktrc%3D (Pubitemid 38365932)
- (2004) Neuropsychopharmacology , vol.29 , Issue.3 , pp. 551-557
- Wang, J.-S.¹ Taylor, R.² Ruan, Y.³ Donovan, J.L.⁴ Markowitz, J.S.⁵ De Vane, C.L.⁶

8
- 5144224887
- 1:CAS:528:DC%2BD2cXntlyiurg%3D
- F Bai LC Iacono B Johnston CF Stewart 2004 J Liq Chromatogr Relat Technol 27 2743 2758 1:CAS:528:DC%2BD2cXntlyiurg%3D
- (2004) J Liq Chromatogr Relat Technol , vol.27 , pp. 2743-2758
- Bai, F.¹ Iacono, L.C.² Johnston, B.³ Stewart, C.F.⁴

9
- 77950930674
- 10.1016/j.jchromb.2010.03.010 1:CAS:528:DC%2BC3cXlt1CksL8%3D
- R Honeywell K Yarzadah E Giovannetti N Losekoot EF Smit M Walraven JSW Lind C Tibaldic HM Verheul GJ Peters 2010 J Chromatogr B Analyt Technol Biomed Life Sci 878 1059 1068 10.1016/j.jchromb.2010.03.010 1:CAS:528: DC%2BC3cXlt1CksL8%3D
- (2010) J Chromatogr B Analyt Technol Biomed Life Sci , vol.878 , pp. 1059-1068
- Honeywell, R.¹ Yarzadah, K.² Giovannetti, E.³ Losekoot, N.⁴ Smit, E.F.⁵ Walraven, M.⁶ Lind, J.S.W.⁷ Tibaldic, C.⁸ Verheul, H.M.⁹ Peters, G.J.¹⁰

10
- 73849128479
- 1:CAS:528:DC%2BD1MXhsV2jtr3N
- A Chahbouni JCG den Burger RM Vos A Sinjewel AJ Wilhelm 2009 Ther Drug Monit 31 683 687 1:CAS:528:DC%2BD1MXhsV2jtr3N
- (2009) Ther Drug Monit , vol.31 , pp. 683-687
- Chahbouni, A.¹ Den Burger, J.C.G.² Vos, R.M.³ Sinjewel, A.⁴ Wilhelm, A.J.⁵

11
- 0037663202
- Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
- DOI 10.1021/ac020361s
- BK Matuszewski ML Constanzer CM Chavez-Eng 2003 Anal Chem 75 3019 3030 10.1021/ac020361s 1:CAS:528:DC%2BD3sXltV2jsL8%3D (Pubitemid 36830428)
- (2003) Analytical Chemistry , vol.75 , Issue.13 , pp. 3019-3030
- Matuszewski, B.K.¹ Constanzer, M.L.² Chavez-Eng, C.M.³

12
- 79959373400
- US Department of Health and Human Services Food and Drug Administration (2001) Lastaccesseddate30Apr2011
- US Department of Health and Human Services Food and Drug Administration (2001) http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf. Last accessed date 30 Apr 2011

13
- 79959376223
- State Food and Drug Administration (2005) Lastaccesseddate30Apr2011
- State Food and Drug Administration (2005) http://www.sda.gov.cn/gsz05106/ 08.pdf. Last accessed date 30 Apr 2011

14
- 14844313671
- Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry
- DOI 10.1016/j.clinbiochem.2004.11.007, LC Mass Spectrometry: Recent Development in Clinical Chemistry
- PJ Taylor 2005 Clin Biochem 38 328 334 10.1016/j.clinbiochem.2004.11.007 1:CAS:528:DC%2BD2MXit1Ciur8%3D (Pubitemid 40342863)
- (2005) Clinical Biochemistry , vol.38 , Issue.4 , pp. 328-334
- Taylor, P.J.¹

15
- 79959373858
- S Shinji Wi Toshihiko M Masaaki N Norimoto H Hisashi 2006 J Neuro-Oncol 3 285 289
- (2006) J Neuro-Oncol , vol.3 , pp. 285-289
- Shinji, S.¹ Wi, T.² Masaaki, M.³ Norimoto, N.⁴ Hisashi, H.⁵

16
- 17144385106
- Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers
- DOI 10.1158/1078-0432.CCR-04-2149
- DH Lee JY Han HG Lee 2005 Clin Cancer Res 11 3032 3037 10.1158/1078-0432.CCR-04-2149 1:CAS:528:DC%2BD2MXjtlejtLc%3D (Pubitemid 40525209)
- (2005) Clinical Cancer Research , vol.11 , Issue.8 , pp. 3032-3037
- Dae, H.L.¹ Han, J.-Y.² Hong, G.L.³ Jae, J.L.⁴ Eun, K.L.⁵ Hyae, Y.K.⁶ Hark, K.K.⁷ Eun, K.H.⁸ Jin, S.L.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.